Doravirine Use in Treatment-Experienced HIV-Positive Patients
Author:
Affiliation:
1. Virginia Commonwealth University Health System, Richmond, VA, USA
Publisher
SAGE Publications
Subject
Pharmacology (medical)
Link
http://journals.sagepub.com/doi/pdf/10.1177/1060028020935763
Reference7 articles.
1. Doravirine: A Return of the NNRTI Class?
2. Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial
3. Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations
4. Prevalence of predicted resistance to doravirine in HIV-1-positive patients after exposure to non-nucleoside reverse transcriptase inhibitors
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Doravirine/lamivudine/tenofovir disoproxil fumarate in virologically suppressed people living with HIV: A real-life experience;International Journal of STD & AIDS;2023-08-11
2. Real-life use of Doravirine in treatment-experienced people living with HIV: A multicenter Italian study;Medicine;2022-07-29
3. Doravirine: its role in HIV treatment;Current Opinion in HIV and AIDS;2021-11-03
4. Real-Life Safety of Doravirine in Treatment-Experienced, Virologically Suppressed PLWHIV;JAIDS Journal of Acquired Immune Deficiency Syndromes;2021-09-01
5. Is there a role for doravirine in African HIV treatment programmes? A large observational resistance study in South Africa;Journal of the International AIDS Society;2021-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3